Helix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Helix and buy or sell other stocks, ETFs, and their options commission-free!

About HLXA

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. 

CEO
Jorge Santos da Silva, PhD
CEOJorge Santos da Silva, PhD
Employees
100
Employees100
Headquarters
Zug, Zug
HeadquartersZug, Zug
Founded
2021
Founded2021
Employees
100
Employees100

HLXA Key Statistics

Market cap
841.03M
Market cap841.03M
Price-Earnings ratio
-20.49
Price-Earnings ratio-20.49
Dividend yield
—
Dividend yield—
Average volume
425.99K
Average volume425.99K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$58.26
52 Week high$58.26
52 Week low
$31.42
52 Week low$31.42

People also own

Based on the portfolios of people who own HLXA. This list is generated using Robinhood data, and it’s not a recommendation.
Clover Health Investments
Robinhood Markets
Tilray Brands
C3.AI
Tuscan
Exxon Mobil
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.